Balance Sheet Data

Corcept Therapeutics Incorporated (CORT)

$25.44

+1.66 (+6.98%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 88.74206.76275.96440.70223.53377.51470.65586.76731.52912
Total Cash (%)
Account Receivables 28.2017.5919.9326.2027.6342.1352.5265.4881.63101.77
Account Receivables (%)
Inventories 4.584.735.424.914.998.4710.5613.1616.4120.45
Inventories (%)
Accounts Payable 8.588.277.5410.556.9114.6118.2122.7028.3135.29
Accounts Payable (%)
Capital Expenditure -0.42-0.30-1.09-1.24-0.47-1.11-1.38-1.72-2.15-2.68
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.